A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Healthy
Interventions
DRUG

BI 706321

Treatment period 1: Single oral dose of 1 film-coated tablet administered with 240 milliliter (mL) of water after an overnight fast of at least 10 hours (h) Treatment period 2: On day 1 of period 2 (1 h after the itraconazole administration) a single oral dose of 1 film-coated tablet administered with 240 mL of water after an overnight fast of at least 10 h.

DRUG

Itraconazole

Treatment period 2: Administered as an oral solution formulation once daily for 14 days orally with 240 mL of water after an overnight fast of at least 9 h, starting from day -3 up to day 11 of period 2.

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04714073 - A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood | Biotech Hunter | Biotech Hunter